Author

Marion Lavergne

Observed names: Lavergne, M., Lavergne, Marion, M. Lavergne

Institutions: Université de Tours, Inserm, Centre d'Étude des Pathologies Respiratoires

Observed institutions: Université de Tours, Karolinska University Hospital, Inserm, University of Cambridge, Karolinska Institutet, ETH Zurich, Centre d'Étude des Pathologies Respiratoires, Biologie et pharmacologie des plaquettes sanguines : hémostase, thrombose, transfusion, Institut National de la Recherche Agronomique, Université de Strasbourg

ORCID: 0000-0002-1337-1121

Observed ORCID: 0000-0002-1337-1121

OpenAlex ID: A5076544611

Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?

2017 · Marion Lavergne, Emily Janus-Bell, et al. · Cancers · 103

Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells

2015 · JongWook Hong, Nicholas P. Tobin, et al. · JNCI Journal of the National Cancer Institute · 76

Purification and Characterization of Avian β-Defensin 11, an Antimicrobial Peptide of the Hen Egg

2010 · Virginie Hervé-Grépinet, Sophie Réhault-Godbert, et al. · Antimicrobial Agents and Chemotherapy · 74

Beneficial role of overexpression of TFPI‐2 on tumour progression in human small cell lung cancer

2013 · Marion Lavergne, Marie-Lise Jourdan, et al. · FEBS Open Bio · 29

Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancer

2012 · Sophie Iochmann, Stéphanie Lerondel, et al. · Lung Cancer · 21

Pro-angiogenic effect of human kallikrein-related peptidase 12 (KLK12) in lung endothelial cells does not depend on kinin-mediated activation of B2 receptor

2012 · Thomas Kryza, Gilles Lalmanach, et al. · Biological Chemistry · 19

Tissue factor pathway inhibitor 2 is a potent kallikrein-related protease 12 inhibitor

2021 · Marion Lavergne, Audrey Guillon-Munos, et al. · Biological Chemistry · 14

Kallikrein‐related peptidase 5 contributes to the remodeling and repair of bronchial epithelium

2021 · Woodys Lenga Ma Bonda, Marion Lavergne, et al. · The FASEB Journal · 13

Rôle du TFPI-2, un inhibiteur de protéases à sérine, dans la progression des cancers broncho-pulmonaires à petites cellules

2013 · Marion Lavergne · theses.fr (ABES)

805 Monitoring of Human Lung Tumour Progression Inhibited by TFPI-2 Using Imaging in Mice Orthotopic Models

2012 · M. Lavergne, S. Iochmann, et al. · European Journal of Cancer

La Kallicréine tissulaire 12, une kallicréine génératrice de kinines ?

2011 · Krysa, Thomas, Lalmanach, Gilles, et al. · HAL

Is human kallikrein related peptidase 12 (KLK12), a novel kininogenase?

2011 · Kryza, T., Lalmanach, G., et al. · HAL

Works count: 12

Citation count: 349

H-index: 8

I10-index: 8